Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-103778
Filing Date
2025-04-29
Accepted
2025-04-29 16:07:22
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d946762ddefa14a.htm DEFA14A 20723
2 GRAPHIC g946762dsp03e.jpg GRAPHIC 5286
3 GRAPHIC g946762dsp1.jpg GRAPHIC 13878
4 GRAPHIC g946762dsp3.jpg GRAPHIC 56655
5 GRAPHIC g946762dsp3a.jpg GRAPHIC 23558
6 GRAPHIC g946762dsp3b.jpg GRAPHIC 3705
7 GRAPHIC g946762dsp3c.jpg GRAPHIC 3082
8 GRAPHIC g946762dsp3d.jpg GRAPHIC 3239
  Complete submission text file 0001193125-25-103778.txt   173514
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38957 | Film No.: 25887232
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)